Wonder Pharmaceuticals announced that Zhang Zhijun, the controlling shareholder of the company, has already implemented a plan to reduce his holdings. The holdings reduction period was from May 28, 2026 to August 20, 2026. Zhang Zhijun reduced his holdings of the company's shares by a total of 14362.35 million shares, accounting for 2.69% of the company's total share capital, and the total amount of reduced holdings was 97.5575 million yuan. Among them, centralized bidding reduced holdings of 5.347 million shares, accounting for 1% of the total share capital, with a price range of 5.14 to 8.13 yuan/share; bulk transactions reduced holdings of 9.021.65 million shares, accounting for 1.69% of the total share capital. After this reduction in holdings was completed, the number of shares held by Zhang Zhijun in the company was 0.

Wonder Pharmaceuticals announced that Zhang Zhijun, the controlling shareholder of the company, has already implemented a plan to reduce his holdings. The holdings reduction period was from May 28, 2026 to August 20, 2026. Zhang Zhijun reduced his holdings of the company's shares by a total of 14362.35 million shares, accounting for 2.69% of the company's total share capital, and the total amount of reduced holdings was 97.5575 million yuan. Among them, centralized bidding reduced holdings of 5.347 million shares, accounting for 1% of the total share capital, with a price range of 5.14 to 8.13 yuan/share; bulk transactions reduced holdings of 9.021.65 million shares, accounting for 1.69% of the total share capital. After this reduction in holdings was completed, the number of shares held by Zhang Zhijun in the company was 0.